Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence
1996

Soluble E-cadherin Levels in Bladder Cancer

Sample size: 40 publication Evidence: moderate

Author Information

Author(s): TRL Griffiths, I Brotherick, RI Bishop, MD White, DM McKenna, CHW Horne, BK Shenton, DE Neal, JK Mellon

Primary Institution: University of Newcastle upon Tyne

Hypothesis

Elevated levels of soluble E-cadherin in serum correlate with known prognostic factors in bladder cancer.

Conclusion

Patients with bladder cancer have significantly higher levels of soluble E-cadherin in their serum compared to controls, and these levels correlate with poor histological grade and recurrence.

Supporting Evidence

  • Patients with bladder cancer had significantly higher concentrations of sE-cadherin compared to a control group.
  • High levels of sE-cadherin were related to poor histological grade and the number of superficial tumors at presentation.
  • Elevated levels of sE-cadherin correlated with a positive 3 month check cystoscopy in superficial disease.

Takeaway

This study found that people with bladder cancer have more of a certain protein in their blood, which might help doctors understand how serious their cancer is.

Methodology

Serum samples from 40 patients with newly diagnosed bladder cancer were analyzed for soluble E-cadherin and other adhesion molecules using ELISA, and tumor samples were assessed for E-cadherin expression via immunohistochemistry.

Limitations

The study only included patients with newly diagnosed bladder cancer and did not assess long-term outcomes.

Participant Demographics

36 males and 4 females, median age 71 years.

Statistical Information

P-Value

0.017

Confidence Interval

95% CI = 161 - 3976 ng ml-1

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication